The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care.
The new edition (BNF 83) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.
Extensive content updates in the
BNF 83 edition include:
New monographs for:
-
- Acarizax® [house dust mite extract] for house dust mite allergic rhinitis or house dust mite allergic asthma
- Adakveo® [crizanlizumab] for vaso-occlusive crises in sickle-cell disease
- Adtralza® [tralokinumab] for atopic eczema
- Bijuve® [estradiol with progesterone] for menopausal symptoms
- Evrenzo® [roxadustat] for symptomatic anaemia associated with chronic kidney disease
- Evrysdi® [risdiplam] for 5q spinal muscular atrophy
- Kesimpta® [ofatumumab] for multiple sclerosis
- Klisyri® [tirbanibulin] for actinic keratosis on face or scalp
- Lagevrio® [molnupiravir] for COVID-19
- Leqvio® [inclisiran] for primary hypercholesterolaemia or mixed dyslipidaemia
- Lumykras® [sotorasib] for non-small cell lung cancer with KRAS G12C mutation
- Ontozry® [cenobamate] for focal seizures with or without secondary generalisation
- Orladeyo® [berotralstat] for hereditary angioedema
- Pemazyre® [pemigatinib] for cholangiocarcinoma with fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement
- Ponvory® [ponesimod] for multiple sclerosis
- Rukobia® [fostemsavir] for HIV drug-resistant infection
- Ryaltris® [mometasone furoate with olopatadine] for allergic rhinitis
- Ryeqo® [relugolix with estradiol and norethisterone acetate] for uterine fibroids
- Verquvo® [vericiguat] for chronic heart failure with reduced ejection fraction
- Zibor® [bemiparin sodium] for prophylaxis of deep-vein thrombosis in general and orthopaedic surgery, and prevention of clotting in extracorporeal circuits
MHRA advice on:
Reviews
There are no reviews yet.